🇺🇸 FDA
Patent

US 9347063

Oligonucleotide analog and method for treating flavivirus infections

granted A61PA61P31/12A61P31/14

Quick answer

US patent 9347063 (Oligonucleotide analog and method for treating flavivirus infections) held by Sarepta Therapeutics, Inc. expires Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sarepta Therapeutics, Inc.
Grant date
Tue May 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 19 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P31/12, A61P31/14, A61P43/00